Fostering the growth of the global health security innovation ecosystem
The five hubs create a network designed to foster the growth of the startup ecosystem by accelerating the development and commercialization of next-generation health security solutions. Each hub sources innovative early-stage ideas in their respective technology areas, and provides funding to assess the feasibility of technology concepts and commercialization resources to accelerate product development and validation.
The BARDA Accelerator Network Hubs
Select a Hub to learn more:
More on our five hubs
Diagnostics / Medical Devices
Consortium led by University Lab Partners, in partnership with CIMIT and Science Exchange
The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Digital Health
Led by MATTER
The Paratus Digital Health Hub supports the development and application of digital health tools to empower people to prepare for and respond to health security threats and improve the continuum of clinical care.
Enabling Technologies
Led by MedTech Innovator (BioTools Innovator)
The BioTools Innovator: VANGUARD Hub supports the development of innovations in drug discovery and development, biomanufacturing innovations to increase speed, capacity, portability, and scalability, and innovations to improve clinical research and clinical care coordination.
Special Populations
Consortium led by Children’s National Hospital, in partnership with CIMIT, University Hospitals Rainbow Babies & Children’s, and BioHealth Innovation
The Special Populations Acceleration, Research and Knowledge (SPARK), Innovations in Pediatrics Hub supports the development of innovations that address challenges around the development and availability of medical countermeasures for pediatric populations.
Therapeutics / Vaccines
Consortium led by Start2 Group, in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs’ (BioLabs)
The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub supports the development and acceleration of next-generation therapeutic and vaccine platforms and technologies.
Services Offered
Wraparound Accelerator
Support Services
The Network supports health security innovators, startups, and BARDA portfolio companies by providing wraparound accelerator services, including entrepreneurship education and access to technical and business/commercialization expertise and resources.
Development, Evaluation, and Validation Services
The Network provides funding to startups to evaluate and validate novel medical countermeasures that align with BARDA’s strategic priorities.
Development, Evaluation, and Validation Services
The Network provides funding to startups to evaluate and validate novel medical countermeasures that align with BARDA’s strategic priorities.
Rapid Response Capability
In the event of a public health emergency, the Network can rapidly fund and accelerate product development and validation of medical countermeasures that can be developed and deployed as quickly as possible.
Learn more about the previous generation of the BARDA Accelerator Network and its partners that continue to support the acceleration of novel life sciences innovations.
Visit PageIf you are interested in working with us, please contact us below:
Contact